To investigate whether NRIP can be a therapeutic target for ALS, this study utilized mice expressing human SOD1 (hSOD1) with the ALS-linked G93A mutation (SOD1 G93A mice) as an ALS model. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.